Jazz Pharmaceuticals
JAZZ
A$178.93
Share price
-0.66%
Change (1 day)
5.35%
Change (1 year)
Categories
Jazz Pharmaceuticals (JAZZ) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : A$11.29 Billion
According to Jazz Pharmaceuticals's latest financial reports the company's total liabilities are A$11.29 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Jazz Pharmaceuticals - Total liabilities on balance sheet (from 2005 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | A$12.73 B | 13.28% |
| 2023-12-31 | A$11.23 B | -1.32% |
| 2022-12-31 | A$11.38 B | -0.93% |
| 2021-12-31 | A$11.49 B | 207.31% |
| 2020-12-31 | A$3.74 B | 7.86% |
| 2019-12-31 | A$3.46 B | -0.13% |
| 2018-12-31 | A$3.47 B | 12.45% |
| 2017-12-31 | A$3.08 B | -23.85% |
| 2016-12-31 | A$4.05 B | 70.36% |
| 2015-12-31 | A$2.38 B | -1.01% |
| 2014-12-31 | A$2.40 B | 127.51% |
| 2013-12-31 | A$1.05 B | 29.94% |
| 2012-12-31 | A$0.81 B | 1271.94% |
| 2011-12-31 | A$59.28 M | -42.75% |
| 2010-12-31 | A$0.10 B | -48.39% |
| 2009-12-31 | A$0.20 B | -32.72% |
| 2008-12-31 | A$0.29 B | 70.88% |
| 2007-12-31 | A$0.17 B | -64.81% |
| 2006-12-31 | A$0.49 B | 28.19% |
| 2005-12-31 | A$0.38 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Endo International
ENDPQ | A$18.00 B | 59.45% | 🇮🇪 Ireland |
 AmerisourceBergen
ABC | A$92.46 B | 718.71% | 🇺🇸 USA |
 Novartis NVS | A$94.36 B | 735.47% | 🇨🇭 Switzerland |
 Teva Pharmaceutical Industries TEVA | A$49.33 B | 336.78% | 🇮🇱 Israel |